, Tracking Stock Market Picks
Enter Symbol:
Mead Johnson Nutrition Company (MJN) [hlAlert]

down 9.25 %

Mead Johnson Nutrition Company (MJN) rated Underperform by BofA/Merrill

Posted on: Thursday,  Oct 8, 2015  10:25 AM ET by BofA/Merrill

BofA/Merrill rated Underperform Mead Johnson Nutrition Company (NYSE: MJN) on 10/08/2015, when the stock price was $71.12. Since
then, Mead Johnson Nutrition Company has gained 10.19% as of 01/08/2016's recent price of $78.37.
If you would have followed this BofA/Merrill's recommendation on MJN, you would have lost 9.25% of your investment in 92 days.

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company?s Enfa family of brands, including Enfamil infant formula, is a global brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. Mead Johnson markets its portfolio of more than 70 products to mothers, health care professionals and retailers in more than 50 countries in North America, Europe, Asia and Latin America. The Company?s two segments include North America/Europe and Asia/Latin America, which comprised 52.4% and 47.6%, respectively, of its net sales during the year ended December 31, 2007. The two principal product categories, in which the Company operates, include infant formula and children?s nutrition. In 2008, Mead Johnson launched Nutramigen AA, an amino acid infant formula for infants with severe protein allergies.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/8/2015 10:25 AM Sell
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy